INTERVIEW: Gert Bos On How The Unexpected Can Pack A Punch In Medtech Regulations
This article was originally published in Clinica
Gert Bos, champion of notified bodies and president of TEAM-NB, knows the medtech regulatory sphere like the back of his hand. He holds interesting and strong views on notified bodies and their evolving role with the ongoing developments in EU medtech regulations. Amanda Maxwell caught up with him, following the announcement of his departure from the notified body BSI to work as an industry consultant
You may also be interested in...
Where are the biggest challenges for notified bodies and manufacturers now there is some experience with the MDR, and can the sector manage the new regulatory requirements successfully?
The European Commission has finally published detailed guidance on the EU IVDR’s classification rules. The IVDR’s completely new classification regime means guidance is urgently needed.
Do you know how to avoid the pitfalls when it comes to clinical evidence under the MDR? Or whether evidence gathered outside the US counts? Amie Smirthwaite of Maetrics answers these and other pivotal questions in this third and final part of an interview series with Medtech Insight.